This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (18) Citing Articles via Google Scholar Google Scholar Articles by Tunis, S. R. Articles by Kang, J. L. Search for Related Content PubMed PubMed Citation Articles by Tunis, S. R. Articles by Kang, J. L. Related Collections Managed Care - Medicare Medicare Research And Technology

Coverage Policy

PERSPECTIVE

Improvements In Medicare Coverage Of New Technology

The speed with which new technology becomes available to patients depends on many factors, with some of the major determinants being investment in basic and applied clinical research, the regulatory approval process of the Food and Drug Administration (FDA), and payers’ decisions as to when they will begin to pay for these technologies.¹ As the largest single payer of health care services in the United States, the Medicare program, through its coverage and payment decisions, can have a major impact on the timing and extent of technology diffusion. This Perspective describes some of the major changes in Medicare’s approach to . . . [Full Text of this Article]

                      What's this?

This article has been cited by other articles:

				J. M. Hoffman, S. S. Gambhir, and G. J. Kelloff Regulatory and Reimbursement Challenges for Molecular Imaging Radiology, December 1, 2007; 245(3): 645 - 660. [Abstract] [Full Text] [PDF]

				S. B. Foote and R. J. Town Implementing Evidence-Based Medicine Through Medicare Coverage Decisions Health Aff., November 1, 2007; 26(6): 1634 - 1642. [Abstract] [Full Text] [PDF]

				R. M. Califf, R. A. Harrington, L. K. Madre, E. D. Peterson, D. Roth, and K. A. Schulman Curbing The Cardiovascular Disease Epidemic: Aligning Industry, Government, Payers, And Academics Health Aff., January 1, 2007; 26(1): 62 - 74. [Abstract] [Full Text] [PDF]

				S. R. Tunis and S. D. Pearson Coverage Options For Promising Technologies: Medicare's 'Coverage With Evidence Development' Health Aff., September 1, 2006; 25(5): 1218 - 1230. [Abstract] [Full Text] [PDF]

				P. S. Keenan, P. J. Neumann, and K. A. Phillips Biotechnology And Medicare's New Technology Policy: Lessons From Three Case Studies Health Aff., September 1, 2006; 25(5): 1260 - 1269. [Abstract] [Full Text] [PDF]

				S. R. Tunis A Clinical Research Strategy To Support Shared Decision Making Health Aff., January 1, 2005; 24(1): 180 - 184. [Abstract] [Full Text] [PDF]

				M. K. Wynia, R. Witlen, S. Hart, M. R. Gillick, and S. R. Tunis Medicare Coverage for Technological Innovations N. Engl. J. Med., August 12, 2004; 351(7): 719 - 720. [Full Text] [PDF]

				S. R. Tunis Why Medicare Has Not Established Criteria for Coverage Decisions N. Engl. J. Med., May 20, 2004; 350(21): 2196 - 2198. [Full Text] [PDF]

				S. R. Tunis and D. B. Stryer Realizing the Benefits of Practical Clinical Trials--Reply JAMA, January 28, 2004; 291(4): 426 - 426. [Full Text] [PDF]

				S. R. Tunis, D. B. Stryer, and C. M. Clancy Practical Clinical Trials: Increasing the Value of Clinical Research for Decision Making in Clinical and Health Policy JAMA, September 24, 2003; 290(12): 1624 - 1632. [Abstract] [Full Text] [PDF]